+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Moderate to Severe Atopic Dermatitis - Pipeline Insight, 2024 - Product Thumbnail Image

Moderate to Severe Atopic Dermatitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Egg allergy - Pipeline Insight, 2024 - Product Thumbnail Image

Egg allergy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Lung transplant rejection - Pipeline Insight, 2024 - Product Thumbnail Image

Lung transplant rejection - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Wiskott-Aldrich Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Wiskott-Aldrich Syndrome - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Rhinitis - Pipeline Insight, 2024 - Product Thumbnail Image

Rhinitis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 90 Pages
  • Global
From
From
Chronic Plaque Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Plaque Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Gouty Arthritis (Gout) - Pipeline Insight, 2024 - Product Thumbnail Image

Gouty Arthritis (Gout) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Uveitis - Pipeline Insight, 2024 - Product Thumbnail Image

Uveitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Alopecia - Pipeline Insight, 2024 - Product Thumbnail Image

Alopecia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 120 Pages
  • Global
From
Lambert-Eaton Myasthenic Syndrome (LEMS) - Pipeline Insight, 2024 - Product Thumbnail Image

Lambert-Eaton Myasthenic Syndrome (LEMS) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Allergic Bronchopulmonary Aspergillosis - Pipeline Insight, 2024 - Product Thumbnail Image

Allergic Bronchopulmonary Aspergillosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Androgenetic Alopecia - Pipeline Insight, 2024 - Product Thumbnail Image

Androgenetic Alopecia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Allergic Rhinitis - Pipeline Insight, 2024 - Product Thumbnail Image

Allergic Rhinitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Systemic Lupus Erythematosus - Pipeline Insight, 2024 - Product Thumbnail Image

Systemic Lupus Erythematosus - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
Plaque Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Plaque Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 240 Pages
  • Global
From
Mucopolysaccharidosis III - Pipeline Insight, 2024 - Product Thumbnail Image

Mucopolysaccharidosis III - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Immunologic Deficiency Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Immunologic Deficiency Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Kidney Transplant Rejection - Pipeline Insight, 2024 - Product Thumbnail Image

Kidney Transplant Rejection - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more